The therapeutic prospect of zinc oxide nanoparticles in experimentally induced diabetic nephropathy

References

• Souto EB, Souto SB, Campos JR, Severino P, Pashirova TN, Zakharova LY, … Santini A. Nanoparticle delivery systems in the treatment of diabetes complications. Molecules. 2019;24(23):1. doi:10.3390/molecules24234209.
   Web of Science ®Google Scholar
• Donate-Correa J, Luis-Rodríguez D, Martín-Núñez E, Tagua VG, Hernández-Carballo C, Ferri C, … Navarro-González JF. Inflammatory targets in diabetic nephropathy. Journal of Clinical Medicine. 2020;9(2):458. doi:10.3390/jcm9020458.
   PubMed Web of Science ®Google Scholar
• Brosius FC, Coward RJ. Podocytes, signaling pathways, and vascular factors in diabetic kidney disease. Adv Chronic Kidney Dis. 2014;21(3):304–20. doi:10.1053/j.ackd.2014.03.011.
   PubMed Web of Science ®Google Scholar
• Gui D, Guo Y, Wang F, Liu W, Chen J, Chen Y, … Wang N. Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo. PloS one. 2012;7(6):e39824. doi:10.1371/journal.pone.0039824.
   PubMed Web of Science ®Google Scholar
• Lu HJ, Tzeng TF, Liou SS, Da Lin S, Wu MC, Liu IM. Polysaccharides from liriopes radix ameliorate streptozotocin-induced type I diabetic nephropathy via regulating NF-κB and p38 MAPK signaling pathways. BMC Complement Altern Med. 2014;14(1):1–12. doi:10.1186/1472-6882-14-156.
   PubMedGoogle Scholar
• Chen S, Chen H, Liu Q, Ma Q. Effect of simvastatin on the expression of nephrin, podocin, and vascular endothelial growth factor (VEGF) in podocytes of diabetic rat. Int J Clin Exp Med. 2015;8:18225.
   PubMed Web of Science ®Google Scholar
• Gilbert RE. Proximal tubulopathy: prime mover and key therapeutic target in diabetic kidney disease. Diabetes. 2017;66(4):791–800‏. doi:10.2337/db16-0796.
   PubMed Web of Science ®Google Scholar
• Takiyama Y, Haneda M. Hypoxia in diabetic kidneys. Biomed Res Int. 2014;2014.
   Web of Science ®Google Scholar
• Isoe T, Makino Y, Mizumoto K, Sakagami H, Fujita Y, Honjo J, … Haneda M. High glucose activates HIF-1-mediated signal transduction in glomerular mesangial cells through a carbohydrate response element binding protein. Kidney Int. 2010;78(1):48–59. doi:10.1038/ki.2010.99.
   PubMed Web of Science ®Google Scholar
• Leung JC, Chan LY, Tsang AW, Tang SC, Lai KN. Differential expression of aquaporins in the kidneys of streptozotocin‐induced diabetic mice. Nephrology. 2005;10:63–72.
   PubMed Web of Science ®Google Scholar
• Atochina-Vasserman EN, Biktasova A, Abramova E, Cheng DS, Polosukhin VV, Tanjore H, … Tchekneva EE. Aquaporin 11 insufficiency modulates kidney susceptibility to oxidative stress. American Journal of Physiology-Renal Physiology. 2013;304(10):F1295–F1307. doi:10.1152/ajprenal.00344.2012.
   PubMed Web of Science ®Google Scholar
• Jia Z, Sun Y, Liu S, Liu Y, Yang T. COX-2 but not mPGES-1 contributes to renal PGE2 induction and diabetic proteinuria in mice with type-1 diabetes. PloS one. 2014;9(7):e93182. doi:10.1371/journal.pone.0093182.
   PubMed Web of Science ®Google Scholar
• Mohamed R, Jayakumar C, Ranganathan PV, Ganapathy V, Ramesh G. Kidney proximal tubular epithelial-specific overexpression of netrin-1 suppresses inflammation and albuminuria through suppression of COX-2-mediated PGE2 production in streptozotocin-induced diabetic mice. Am J Pathol. 2012;181(6):1991–2002‏. doi:10.1016/j.ajpath.2012.08.014.
   PubMed Web of Science ®Google Scholar
• Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. diabetes. 2005;54(6):1615–1625. doi:10.2337/diabetes.54.6.1615.
   PubMed Web of Science ®Google Scholar
• Ding Y, Choi ME. Autophagy in diabetic nephropathy. J Endocrinol. 2015;224(1):R15. doi:10.1530/JOE-14-0437.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhou Q, Xin W, Li Z, Chen L, Wan Q. Autophagy downregulation contributes to insulin resistance mediated injury in insulin receptor knockout podocytes in vitro. PeerJ. 2016;4:e1888. doi:10.7717/peerj.1888.
   PubMed Web of Science ®Google Scholar
• Lin YC, Chang YH, Yang SY, Wu KD, Chu TS. Update of pathophysiology and management of diabetic kidney disease. Journal of the Formosan Medical Association. 2018;117(8):662–675. doi:10.1016/j.jfma.2018.02.007.
   PubMed Web of Science ®Google Scholar
• Sinha S, Levine B. The autophagy effector beclin 1: a novel BH3-only protein. Oncogene. 2008;27(S1):S137–S148. doi:10.1038/onc.2009.51.
   PubMedGoogle Scholar
• Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell. 2010;140(3):313–326. doi:10.1016/j.cell.2010.01.028.
   PubMed Web of Science ®Google Scholar
• Liu WJ, Gan Y, Huang WF, Wu HL, Zhang XQ, Zheng HJ, Liu HF. Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease. Cell Death Dis. 2019;10(11):1–17‏. doi:10.1038/s41419-019-2002-6.
   Google Scholar
• Chasapis CT, Loutsidou AC, Spiliopoulou CA, Stefanidou ME. Zinc and human health: an update. Arch Toxicol. 2012;86(4):521–534. doi:10.1007/s00204-011-0775-1.
   PubMed Web of Science ®Google Scholar
• Jansen J, Karges W, Rink L. Zinc and diabetes—clinical links and molecular mechanisms. J Nutr Biochem. 2009;20(6):399–417. doi:10.1016/j.jnutbio.2009.01.009.
   PubMed Web of Science ®Google Scholar
• Chabosseau P, Rutter GA. Zinc and diabetes. Arch Biochem Biophys. 2016;611:79–85. doi:10.1016/j.abb.2016.05.022.
   PubMed Web of Science ®Google Scholar
• Olechnowicz J, Tinkov A, Skalny A, Suliburska J. Zinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolism. The Journal of Physiological Sciences. 2018;68(1):19–31. doi:10.1007/s12576-017-0571-7.
   PubMed Web of Science ®Google Scholar
• Umrani RD, Paknikar KM. Zinc oxide nanoparticles show antidiabetic activity in streptozotocin-induced type 1 and 2 diabetic rats. Nanomedicine. 2014;9(1):89–104. doi:10.2217/nnm.12.205.
   PubMed Web of Science ®Google Scholar
• Mosquera J, García I, Liz-Marzán LM. Cellular uptake of nanoparticles versus small molecules: a matter of size. Acc Chem Res. 2018;51(9):2305–2313. doi:10.1021/acs.accounts.8b00292.
   PubMed Web of Science ®Google Scholar
• Ebrahim N, Ahmed IA, Hussien NI, Dessouky AA, Farid AS, Elshazly AM, … Sabry D. Mesenchymal stem cell-derived exosomes ameliorated diabetic nephropathy by autophagy induction through the mTOR signaling pathway. Cells. 2018;7(12):226. doi:10.3390/cells7120226.
   PubMed Web of Science ®Google Scholar
• Wahba NS, Shaban SF, Kattaia AA, Kandeel SA. Efficacy of zinc oxide nanoparticles in attenuating pancreatic damage in a rat model of streptozotocin-induced diabetes. Ultrastruct Pathol. 2016;40(6):358–373. doi:10.1080/01913123.2016.1246499.
   PubMed Web of Science ®Google Scholar
• Ko JW, Hong ET, Lee IC, Park SH, Park JI, Seong NW, … Kim JC. Evaluation of 2-week repeated oral dose toxicity of 100 nm zinc oxide nanoparticles in rats. Lab Anim Res. 2015;31(3):139–147. doi:10.5625/lar.2015.31.3.139.
   PubMedGoogle Scholar
• Wen L, Gao Q, Ma CW, Ge Y, You L, Liu RH, … Liu D. Effect of polysaccharides from Tremella fuciformis on UV-induced photoaging. J Funct Foods. 2016;20:400–410. doi:10.1016/j.jff.2015.11.014.
   Web of Science ®Google Scholar
• Tietz NW, Pruden EL, Fuhrman SA. Eds., Clinical guide to laboratory tests. 1995: Saunders.‏.
   Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. methods. 2001;25(4):402–408‏. doi:10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• Bancroft JD, Gamble M. Eds., 2008: Theory and practice of histological techniques.Elsevier health sciences.‏
   Google Scholar
• Ayache J, Beaunier L, Boumendil J, Ehret G, Laub D. Sample preparation handbook for transmission electron microscopy techniques. New York: Springer Science and Businesss Media; 2010.
   Google Scholar
• Verma R, Wharram B, Kovari I, Kunkel R, Nihalani D, Wary KK, … Holzman LB. Fyn binds to and phosphorylates the kidney slit diaphragm component nephrin. Journal of Biological Chemistry. 2003;278(23):20716–20723. doi:10.1074/jbc.M301689200.
   PubMed Web of Science ®Google Scholar
• Alomari G, Al-Trad B, Hamdan S, Aljabali A, Al-Zoubi M, Bataineh N, … Tambuwala MM. Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy. Drug Deliv Transl Res. 2020;10(1):216–226. doi:10.1007/s13346-019-00675-6.
   PubMed Web of Science ®Google Scholar
• Eid AA, Gorin Y, Fagg BM, Maalouf R, Barnes JL, Block K, Abboud HE. Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes. 2009;58(5):1201–1211. doi:10.2337/db08-1536.
   PubMed Web of Science ®Google Scholar
• Jim B, Ghanta M, Qipo A, Fan Y, Chuang PY, Cohen HW, … He JC. Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study. PloS one. 2012;7(5):e36041. doi:10.1371/journal.pone.0036041.
   PubMed Web of Science ®Google Scholar
• Raparia K, Usman I, Kanwar YS. Renal morphologic lesions reminiscent of diabetic nephropathy. Arch Pathol Lab Med. 2013;137(3):351–359‏. doi:10.5858/arpa.2012-0243-RA.
   PubMed Web of Science ®Google Scholar
• Baines RJ, Brunskill NJ. Tubular toxicity of proteinuria. Nat Rev Nephrol. 2011;7(3):177–180. doi:10.1038/nrneph.2010.174.
   PubMed Web of Science ®Google Scholar
• Nastase MV, Zeng-Brouwers J, Wygrecka M, Schaefer L. Targeting renal fibrosis: mechanisms and drug delivery systems. Adv Drug Deliv Rev. 2018;129:295–307‏. doi:10.1016/j.addr.2017.12.019.
   PubMed Web of Science ®Google Scholar
• Melmed S, Polonsky KS, Larsen PR, Kronenberg HM. Williams textbook of endocrinology E-Book. Elsevier Health Sciences.‏; 2015.
   Google Scholar
• Nangaku M, Inagi R, Miyata T, Fujita T. Hypoxia and hypoxia-inducible factor in renal disease. Nephron Exp Nephrol. 2008;110(1):e1–e7. doi:10.1159/000148256.
   PubMedGoogle Scholar
• Diebold I, Petry A, Hess J, Görlach A. The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol Biol Cell. 2010;21(12):2087–2096‏. doi:10.1091/mbc.e09-12-1003.
   PubMed Web of Science ®Google Scholar
• Brukamp K, Jim B, Moeller MJ, Haase VH. Hypoxia and podocyte-specific vhlh deletion confer risk of glomerular disease. American Journal of Physiology-Renal Physiology. 2007;293(4):F1397–F1407. doi:10.1152/ajprenal.00133.2007.
   PubMed Web of Science ®Google Scholar
• Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, Saito Y, Johnson RS, Kretzler M, Cohen CD, et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest. 2007;117(12):3810–3820. doi:10.1172/JCI30487.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang W, Jiang T, Yang B. Aquaporins in urinary system. Aquaporins. 2017;131–148.
   Google Scholar
• Soveral G, Casini A. Aquaporin modulators: a patent review. Expert Opin Ther Pat. 2010–2015 2017;27(1):49–62. doi:10.1080/13543776.2017.1236085.
   Google Scholar
• Choma DP, Vanacore R, Naylor H, Zimmerman IA, Pavlichenko A, Pavlichenko A, Foye L, Carbone DP, Harris RC, Dikov MM, et al. Aquaporin 11 variant associates with kidney disease in type 2 diabetic patients. American Journal of Physiology-Renal Physiology. 2016;310(5):F416–F425. doi:10.1152/ajprenal.00295.2015.
   PubMed Web of Science ®Google Scholar
• Shafaei H, Rad JS, Behjati M, Behjati M. The effect of pulp and seed extract of citrullus colocynthis, as an antidaibetic medicinal herb, on hepatocytes glycogen stores in diabetic rabbits. Advanced Biomedical Research. 2014 Advanced biomedical research, 3.‏;3(1):258. doi:10.4103/2277-9175.148230.
   PubMedGoogle Scholar
• Forbes JM, Fukami K, Cooper ME. Diabetic nephropathy: where hemodynamics meets metabolism. Experimental and Clinical Endocrinology & Diabetes. 2007;115(2):69–84. doi:10.1055/s-2007-949721.
   PubMed Web of Science ®Google Scholar
• Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, … Danesh FR. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med. 2008;233(1):4–11. doi:10.3181/0705-MR-134.
   PubMed Web of Science ®Google Scholar
• Kim WY, Nam SA, Song HC, Ko JS, Park SH, Kim HL, … Kim YK. The role of autophagy in unilateral ureteral obstruction rat model. Nephrology. 2012;17(2):148–159‏. doi:10.1111/j.1440-1797.2011.01541.x.
   PubMed Web of Science ®Google Scholar
• Zhu J, Wang KZ, Chu CT. After the banquet: mitochondrial biogenesis, mitophagy, and cell survival. Autophagy. 2013;9(11):1663–1676. doi:10.4161/auto.24135.
   PubMed Web of Science ®Google Scholar
• Bhang SH, Lee S, Shin JY, Lee TJ, Jang HK, Kim BS. Efficacious and clinically relevant conditioned medium of human adipose-derived stem cells for therapeutic angiogenesis. Molecular Therapy. 2014;22(4):862–872. doi:10.1038/mt.2013.301.
   PubMed Web of Science ®Google Scholar
• Wang X, Sun D, Hu Y, Xu X, Jiang W, Shang H, Cui D. The roles of oxidative stress and Beclin-1 in the autophagosome clearance impairment triggered by cardiac arrest. Free Radic Biol Med. 2019;136:87–95. doi:10.1016/j.freeradbiomed.2018.12.039.
   PubMed Web of Science ®Google Scholar
• Guo C, Yang M, Jing LI, Wang J, Yu Y, Li Y, … Sun Z. Amorphous silica nanoparticles trigger vascular endothelial cell injury through apoptosis and autophagy via reactive oxygen species-mediated MAPK/Bcl-2 and PI3K/Akt/mTOR signaling. Int J Nanomedicine. 2016;11:5257.
   PubMed Web of Science ®Google Scholar
• Fernando J, Zhou S. The role of zinc in renal pathological changes in diabetic status.‏. 2015.
   Google Scholar
• Yang Z, Pu M, Dong X, Ji F, Veeraraghavan VP, Yang H. Piperine loaded zinc oxide nanocomposite inhibits the PI3K/AKT/mTOR signaling pathway via attenuating the development of gastric carcinoma: in vitro and in vivo studies. Arabian Journal of Chemistry. 2020;13(5):5501–5516‏. doi:10.1016/j.arabjc.2020.03.028.
   Web of Science ®Google Scholar
• Baek M, Chung H-E, Yu J, Lee J-A, Kim T-H, Oh J-M, Lee W-J, Paek S-M, Lee JK, Jeong J. Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. Int J Nanomedicine. 2012;7:3081. doi:10.2147/IJN.S32593.
   PubMed Web of Science ®Google Scholar
• Wang X, Valenzano MC, Mercado JM, Zurbach EP, Flounders CJ, Mullin JM. Zinc enhancement of LLC-PK(1) renal epithelial barrier function. Clinical Nutrition (Edinburgh, Scotland). 2014;33(2):280–286. Clinical nutrition. doi:10.1016/j.clnu.2013.05.001.
   PubMed Web of Science ®Google Scholar
• Alkaladi A, Abdelazim AM, Afifi M. Antidiabetic activity of zinc oxide and silver nanoparticles on streptozotocin-induced diabetic rats. Int J Mol Sci. 2014;15(2):2015–2023. doi:10.3390/ijms15022015.
   PubMed Web of Science ®Google Scholar
• Quesada I, Tudurí E, Ripoll C, Nadal A. Physiology of the pancreatic α-cell and glucagon secretion: role in glucose homeostasis and diabetes. Journal of Endocrinology. 2008;199(1):5–19‏. doi:10.1677/JOE-08-0290.
   PubMed Web of Science ®Google Scholar
• Egefjord L, Petersen AB, Bak AM, Rungby J. Zinc, alpha cells and glucagon secretion. Curr Diabetes Rev. 2010;6(1):52–57. doi:10.2174/157339910790442655.
   PubMedGoogle Scholar
• Nagajyothi PC, Cha SJ, Yang IJ, Sreekanth TVM, Kim KJ, Shin HM. Antioxidant and anti-inflammatory activities of zinc oxide nanoparticles synthesized using Polygala tenuifolia root extract. J Photochem Photobiol B. 2015;146:10–17. doi:10.1016/j.jphotobiol.2015.02.008.
   PubMed Web of Science ®Google Scholar
• Kim MH, Jeong HJ. Zinc oxide nanoparticles suppress LPS-induced NF-κB activation by Inducing A20, a negative regulator of NF-κB, in RAW 264.7 macrophages. J Nanosci Nanotechnol. 2015;15(9):6509–6515. doi:10.1166/jnn.2015.10319.
   PubMed Web of Science ®Google Scholar
• Jia L, Hao SL, Yang WX. Nanoparticles induce autophagy via mTOR pathway inhibition and reactive oxygen species generation. Nanomedicine. 2020;15(14):1419–1435‏. doi:10.2217/nnm-2019-0387.
   PubMed Web of Science ®Google Scholar
• Xue R, Zhai R, Xie L, Zheng Z, Jian G, Chen T, Gui D. Xuesaitong protects podocytes from apoptosis in diabetic rats through modulating PTEN-PDK1-Akt-mTOR pathway. J Diabetes Res. 2020;2020:1–12. doi:10.1155/2020/9309768.
   Web of Science ®Google Scholar
• Bai DP, Zhang XF, Zhang GL, Huang YF, Gurunathan S. Zinc oxide nanoparticles induce apoptosis and autophagy in human ovarian cancer cells. Int J Nanomedicine. 2017;12:6521. doi:10.2147/IJN.S140071.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yin H, Li Z, Zhang T, Yang Z. Nano-TiO 2 induces autophagy to protect against cell death through antioxidative mechanism in podocytes. Cell Biol Toxicol. 2016;32(6):513–527. doi:10.1007/s10565-016-9352-y.
   PubMed Web of Science ®Google Scholar
• Roy R, Singh SK, Chauhan LKS, Das M, Tripathi A, Dwivedi PD. Zinc oxide nanoparticles induce apoptosis by enhancement of autophagy via PI3K/Akt/mTOR inhibition. Toxicol Lett. 2014;227(1):29–40. doi:10.1016/j.toxlet.2014.02.024.
   PubMed Web of Science ®Google Scholar